MARSHALL WACE, LLP

Position in PRLD — Prelude Therapeutics Inc

CIK 1318757 LONDON, X0

Position in PRLD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,016,388

-$211,070 QoQ

Shares Held

190,692

-46.9% QoQ

Ownership

0.239%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 75 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. PRLD ranks #178 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,016,388	190,692	-46.9%	Shares	Other	2026-08-13
2026-03-31	$1,227,458	358,906	+31.0%	Shares	Other	2026-05-15
2025-12-31	$794,260	273,883	+556.1%	Shares	Other	2026-02-13
2025-06-30	$33,772	41,747	-89.4%	Shares	Other	2025-08-13
2024-12-31	$499,996	392,155	+9.2%	Shares	Other	2025-02-13
2024-09-30	$743,413	359,137	+685.6%	Shares	Other	2024-11-14
2022-06-30	$238,636	45,716	-59.1%	Shares	Other	2022-08-15
2022-03-31	$771,261	111,777	-58.3%	Shares	Other	2022-05-16
2021-12-31	$3,336,823	268,018	+814.3%	Shares	Other	2022-02-14
2021-03-31	$1,270,218	29,315	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.